KCNH2 and cancer: Its anti-proliferative activity occurs through different mechanisms, namely by targeting proteins involved in cancer progression including human ether a-go-go 1 (hEag1) and Eag-related gene (hErg) potassium channels [83, 85–89] and by modulating autophagy [84].